• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组测序用于抗菌药物监测:来自 2021 年和 2022 年欧盟抗菌药物耐药参考实验室基因组能力测试网络的针对特定物种的质量阈值和数据评估。

Whole-genome sequencing for antimicrobial surveillance: species-specific quality thresholds and data evaluation from the network of the European Union Reference Laboratory for Antimicrobial Resistance genomic proficiency tests of 2021 and 2022.

机构信息

National Food Institute, Technical University of Denmark, Research Group for Global Capacity Building, European Union Reference Laboratory for Antimicrobial Resistance, Kongens Lyngby, Denmark.

Wageningen Bioveterinary Research part of Wageningen University and Research, Lelystad, the Netherlands.

出版信息

mSystems. 2024 Sep 17;9(9):e0016024. doi: 10.1128/msystems.00160-24. Epub 2024 Aug 6.

DOI:10.1128/msystems.00160-24
PMID:39105591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11406893/
Abstract

As antimicrobial resistance (AMR) surveillance shifts to genomics, ensuring the quality of whole-genome sequencing (WGS) data produced across laboratories is critical. Participation in genomic proficiency tests (GPTs) not only increases individual laboratories' WGS capacity but also provides a unique opportunity to improve species-specific thresholds for WGS quality control (QC) by repeated resequencing of distinct isolates. Here, we present the results of the EU Reference Laboratory for Antimicrobial Resistance (EURL-AR) network GPTs of 2021 and 2022, which included 25 EU national reference laboratories (NLRs). A total of 392 genomes from 12 AMR-bacteria were evaluated based on WGS QC metrics. Two percent ( = 9) of the data were excluded, due to contamination, and 11% ( = 41) of the remaining genomes were identified as outliers in at least one QC metric and excluded from computation of the adjusted QC thresholds (AQT). Two QC metric correlation groups were identified through linear regression. Eight percent ( = 28) of the submitted genomes, from 11 laboratories, failed one or more of the AQTs. However, only three laboratories (12%) were identified as underperformers, failing across AQTs for uncorrelated QC metrics in at least two genomes. Finally, new species-specific thresholds for "N50" and "number of contigs > 200 bp" are presented for guidance in routine laboratory QC. The continued participation of NRLs in GPTs will reveal WGS workflow flaws and improve AMR surveillance data. GPT data will continue to contribute to the development of reliable species-specific thresholds for routine WGS QC, standardizing sequencing data QC and ensure inter- and intranational laboratory comparability.IMPORTANCEIllumina next-generation sequencing is an integral part of antimicrobial resistance (AMR) surveillance and the most widely used whole-genome sequencing (WGS) platform. The high-throughput, relative low-cost, high discriminatory power, and rapid turnaround time of WGS compared to classical biochemical methods means the technology will likely remain a fundamental tool in AMR surveillance and public health. In this study, we present the current level of WGS capacity among national reference laboratories in the EU Reference Laboratory for AMR network, summarizing applied methodology and statistically evaluating the quality of the obtained sequence data. These findings provide the basis for setting new and revised thresholds for quality metrics used in routine WGS, which have previously been arbitrarily defined. In addition, underperforming participants are identified and encouraged to evaluate their workflows to produce reliable results.

摘要

随着抗生素耐药性(AMR)监测向基因组学转移,确保实验室之间产生的全基因组测序(WGS)数据的质量至关重要。参与基因组能力验证测试(GPT)不仅可以提高各个实验室的 WGS 能力,还为通过对不同分离株的重复重测序来提高 WGS 质量控制(QC)的特定物种阈值提供了独特的机会。在这里,我们展示了欧盟抗生素耐药性参考实验室(EURL-AR)网络 2021 年和 2022 年 GPT 的结果,其中包括 25 个欧盟国家参考实验室(NLR)。根据 WGS QC 指标,对来自 12 种 AMR 细菌的 392 个基因组进行了评估。由于污染,有 2%(=9)的数据被排除在外,其余 11%(=41)的基因组在至少一个 QC 指标中被确定为异常值,并被排除在调整后的 QC 阈值(AQT)计算之外。通过线性回归确定了两个 QC 度量相关组。在提交的基因组中,有 11 个实验室的 8%(=28)个不符合一个或多个 AQT。然而,只有三个实验室(12%)被确定为表现不佳,在至少两个基因组中,不相关的 QC 指标的 AQT 都未通过。最后,提出了用于常规实验室 QC 的“N50”和“>200bp 碱基对的碱基对数”的新的特定物种阈值。国家参考实验室继续参与 GPT 将揭示 WGS 工作流程中的缺陷并改善 AMR 监测数据。GPT 数据将继续为常规 WGS QC 的可靠特定物种阈值的制定做出贡献,从而标准化测序数据 QC,并确保实验室之间和国家之间的可比性。

重要性:Illumina 下一代测序是抗生素耐药性(AMR)监测的重要组成部分,也是最广泛使用的全基因组测序(WGS)平台。与传统生化方法相比,WGS 具有高通量、相对低成本、高区分能力和快速周转时间的特点,这意味着该技术仍将是 AMR 监测和公共卫生的基本工具。在这项研究中,我们展示了欧盟抗生素耐药性参考实验室网络中国家参考实验室的当前 WGS 能力水平,总结了应用方法,并从统计学上评估了获得的序列数据的质量。这些发现为设定常规 WGS 中使用的质量指标的新的和修订的阈值提供了基础,这些阈值以前是任意定义的。此外,确定了表现不佳的参与者,并鼓励他们评估其工作流程以产生可靠的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92be/11406893/0f5934661f77/msystems.00160-24.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92be/11406893/1abd8c7b24b2/msystems.00160-24.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92be/11406893/e5c6a916ebcc/msystems.00160-24.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92be/11406893/0f5934661f77/msystems.00160-24.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92be/11406893/1abd8c7b24b2/msystems.00160-24.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92be/11406893/e5c6a916ebcc/msystems.00160-24.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92be/11406893/0f5934661f77/msystems.00160-24.f003.jpg

相似文献

1
Whole-genome sequencing for antimicrobial surveillance: species-specific quality thresholds and data evaluation from the network of the European Union Reference Laboratory for Antimicrobial Resistance genomic proficiency tests of 2021 and 2022.全基因组测序用于抗菌药物监测:来自 2021 年和 2022 年欧盟抗菌药物耐药参考实验室基因组能力测试网络的针对特定物种的质量阈值和数据评估。
mSystems. 2024 Sep 17;9(9):e0016024. doi: 10.1128/msystems.00160-24. Epub 2024 Aug 6.
2
Results of the 2020 Genomic Proficiency Test for the network of European Union Reference Laboratory for Antimicrobial Resistance assessing whole-genome-sequencing capacities.2020 年欧盟抗菌药物耐药性参考实验室网络全基因组测序能力能力验证的结果。
Microb Genom. 2023 Aug;9(8). doi: 10.1099/mgen.0.001076.
3
Proficiency testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories.细菌全基因组测序能力验证确保临床和公共卫生实验室微生物诊断质量
Pathology. 2021 Dec;53(7):902-911. doi: 10.1016/j.pathol.2021.03.012. Epub 2021 Jul 15.
4
Integrating Scalable Genome Sequencing Into Microbiology Laboratories for Routine Antimicrobial Resistance Surveillance.将可扩展基因组测序整合到微生物学实验室中,用于常规抗菌药物耐药性监测。
Clin Infect Dis. 2021 Dec 1;73(Suppl_4):S258-S266. doi: 10.1093/cid/ciab796.
5
Discordant bioinformatic predictions of antimicrobial resistance from whole-genome sequencing data of bacterial isolates: an inter-laboratory study.从细菌分离物的全基因组测序数据中得出的抗菌药物耐药性的生物信息学预测结果不一致:一项实验室间研究。
Microb Genom. 2020 Feb;6(2). doi: 10.1099/mgen.0.000335. Epub 2020 Feb 12.
6
The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee.全基因组测序在细菌抗菌药物敏感性试验中的作用:来自 EUCAST 分委会的报告。
Clin Microbiol Infect. 2017 Jan;23(1):2-22. doi: 10.1016/j.cmi.2016.11.012. Epub 2016 Nov 23.
7
Establishing a national reference laboratory for antimicrobial resistance using a whole-genome sequencing framework: Nigeria's experience.建立一个使用全基因组测序框架的国家抗菌药物耐药性参考实验室:尼日利亚的经验。
Microbiology (Reading). 2022 Aug;168(8). doi: 10.1099/mic.0.001208.
8
Survey on the Use of Whole-Genome Sequencing for Infectious Diseases Surveillance: Rapid Expansion of European National Capacities, 2015-2016.2015 - 2016年欧洲各国利用全基因组测序进行传染病监测的调查:国家能力的快速扩张
Front Public Health. 2017 Dec 18;5:347. doi: 10.3389/fpubh.2017.00347. eCollection 2017.
9
clustering to reveal major European whole-genome-sequencing-based genogroups in association with antimicrobial resistance.聚类分析揭示了与抗菌药物耐药性相关的主要基于全基因组测序的欧洲基因群。
Microb Genom. 2021 Feb;7(2). doi: 10.1099/mgen.0.000481.
10
WGS-Based Prediction and Analysis of Antimicrobial Resistance in Isolates From Israel.基于全基因组测序的以色列分离株抗菌药物耐药性预测与分析
Front Cell Infect Microbiol. 2020 Aug 13;10:365. doi: 10.3389/fcimb.2020.00365. eCollection 2020.

引用本文的文献

1
Tracking of multidrug-resistant pathogen clones in Ghana: a systematic review and meta-analysis.加纳耐多药病原体克隆的追踪:系统评价与荟萃分析
BMC Med Genomics. 2025 Aug 27;18(1):137. doi: 10.1186/s12920-025-02161-0.
2
Epidemiological and molecular investigation of a Salmonella Agona-associated foodborne outbreak in Taiyuan, Shanxi Province, China, 2022.2022年中国山西省太原市一起与阿哥纳沙门氏菌相关的食源性疾病暴发的流行病学和分子调查
BMC Infect Dis. 2025 Jul 24;25(1):943. doi: 10.1186/s12879-025-11305-7.

本文引用的文献

1
Genomic surveillance for antimicrobial resistance - a One Health perspective.抗菌药物耐药性的基因组监测——一种从“同一健康”角度出发的方法。
Nat Rev Genet. 2024 Feb;25(2):142-157. doi: 10.1038/s41576-023-00649-y. Epub 2023 Sep 25.
2
Results of the 2020 Genomic Proficiency Test for the network of European Union Reference Laboratory for Antimicrobial Resistance assessing whole-genome-sequencing capacities.2020 年欧盟抗菌药物耐药性参考实验室网络全基因组测序能力能力验证的结果。
Microb Genom. 2023 Aug;9(8). doi: 10.1099/mgen.0.001076.
3
Next-Generation Sequencing Technology: Current Trends and Advancements.
下一代测序技术:当前趋势与进展
Biology (Basel). 2023 Jul 13;12(7):997. doi: 10.3390/biology12070997.
4
Benchmarking of Nanopore R10.4 and R9.4.1 flow cells in single-cell whole-genome amplification and whole-genome shotgun sequencing.纳米孔R10.4和R9.4.1流动槽在单细胞全基因组扩增和全基因组鸟枪法测序中的基准测试
Comput Struct Biotechnol J. 2023 Mar 24;21:2352-2364. doi: 10.1016/j.csbj.2023.03.038. eCollection 2023.
5
An Introduction to Nanopore Sequencing: Past, Present, and Future Considerations.纳米孔测序简介:过去、现在及未来考量
Micromachines (Basel). 2023 Feb 16;14(2):459. doi: 10.3390/mi14020459.
6
Comparison of R9.4.1/Kit10 and R10/Kit12 Oxford Nanopore flowcells and chemistries in bacterial genome reconstruction.比较 R9.4.1/Kit10 和 R10/Kit12 Oxford Nanopore 流动池和化学试剂在细菌基因组重建中的应用。
Microb Genom. 2023 Jan;9(1). doi: 10.1099/mgen.0.000910.
7
Automated antimicrobial susceptibility testing and antimicrobial resistance genotyping using Illumina and Oxford Nanopore Technologies sequencing data among .使用Illumina和牛津纳米孔技术测序数据进行自动化抗菌药物敏感性测试和抗菌药物耐药基因分型,在……之中
Front Microbiol. 2022 Aug 8;13:973605. doi: 10.3389/fmicb.2022.973605. eCollection 2022.
8
The efficiency of Nextera XT tagmentation depends on G and C bases in the binding motif leading to uneven coverage in bacterial species with low and neutral GC-content.Nextera XT转座酶切反应的效率取决于结合基序中的G和C碱基,这导致在GC含量低和中等的细菌物种中覆盖不均匀。
Front Microbiol. 2022 Jul 14;13:944770. doi: 10.3389/fmicb.2022.944770. eCollection 2022.
9
Comparison of Illumina and Oxford Nanopore Sequencing Technologies for Pathogen Detection from Clinical Matrices Using Molecular Inversion Probes.Illumina 和 Oxford Nanopore 测序技术在基于分子反转探针的临床样本病原体检测中的比较。
J Mol Diagn. 2022 Apr;24(4):395-405. doi: 10.1016/j.jmoldx.2021.12.005. Epub 2022 Jan 25.
10
Prevalence, Risk Factors, and Genetic Characterization of Extended-Spectrum Beta-Lactamase Isolated From Healthy Pregnant Women in Madagascar.从马达加斯加健康孕妇中分离出的超广谱β-内酰胺酶的流行情况、危险因素及基因特征
Front Microbiol. 2021 Dec 24;12:786146. doi: 10.3389/fmicb.2021.786146. eCollection 2021.